Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Aebi, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Aebi, S.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Annals of Oncology 15:1149-1150, 2004
© 2004 European Society for Medical Oncology

Endometrial cancer: a frequent orphan disease

S. Aebi

Institute of Medical Oncology, University Hospital, Inselspital, 3010 Bern, Switzerland

Email: stefan.aebi@insel.ch

The first 10% of the full text of this article appears below.

Endometrial cancer is the most frequent invasive cancer of the female genital tract, with an estimated annual incidence of almost 38 000 in the ‘old’ European Union (before 1 May 2004) and a similar figure in the United States. It is substantially more frequent than ovarian cancer, but can be cured more often by surgery and radiation therapy; this results in about 9000 deaths per year in the EU and 7000 in the United States [1Go,2Go]. Epidemiological risk factors for endometrial cancer are well known [3Go], but the optimal therapy of endometrial cancer . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?